Neucure Lifesciences Private Limited
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimzab MV 2mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Glimzab MV 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimzab MV 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimzab MV 2mg/500mg/0.3mg Tablet.
Glimzab MV 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimzab MV 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimzab MV 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glimzab MV 2mg/500mg/0.3mg Tablet contains a combination of three medicines: Glimepiride, Metformin and Voglibose. It's used in treating Type 2 diabetes mellitus (DM). This medicine helps regulate blood glucose levels in adults when taken with proper diet and exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, while Voglibose inhibits alpha-glucosidase to reduce postprandial glucose levels after meals.
Common side effects of Glimzab MV 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infections.
Avoid using Glimzab MV 2mg/500mg/0.3mg Tablet if you have: - Allergies to any of its components or excipients.<br> - Moderate to severe kidney disease<br> - Inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, Glimzab MV 2mg/500mg/0.3mg Tablet should not be taken with alcohol. This combination may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimzab MV 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It's more likely with missed meals, alcohol consumption, over-exercising, and other antidiabetic medications. Regular monitoring of blood glucose levels is important.
Store Glimzab MV 2mg/500mg/0.3mg Tablet in its original container, tightly closed and according to its packaging's instructions. Do not discard unused medication. It should be kept out of reach of pets, children, and other individuals.